11th International Congress on Autoimmunity

      Date
      May 16, 2018 - May 20, 2018
      Location
      Portugal
      The 11th International Congress on Autoimmunity is the only meeting where you can learn about more than 80 autoimmune diseases from a variety of perspectives, both research-based and clinical. discussed topics will include the newest therapeutic techniques and diagnostic tools as well as the most up-to-date research on genetic, etiology, diagnostic, clinical aspects and novel therapies of autoimmune diseases. Established by Professor Yehuda Shoenfeld, this autoimmunity congress constitutes a network of international leaders on immunology, rheumatology and related fields, all of whom contribute their unique and diverse knowledge to the “family of autoimmunity.” And for the first time in 2018 the Academy of Autoimmunity, a systematic course on autoimmune diseases, will be presented.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.